ASTRAZENECA PHARMACEUTICALS LP
Federal contractor profile
Total Awards
11
Total $
$11.6M
Top Agency
Department of Health and Human Services
NAICS Count
2
Total Awards
11
Total Obligated
$11.6M
Agencies Served
3
Expiring Contracts
1
Top Agencies
| Agency | Awards | Total Obligated |
|---|---|---|
| Department of Health and Human Services | 4 | $11.6M |
| Department of Defense | 2 | $500 |
| Department of Veterans Affairs | 5 |
Top NAICS Codes
Expiring Contracts (1)
All Awards
FIRM FIXED PRICENO SET ASIDE USED.
2025-6 PEDIATRIC FLU VACCINES
Department of Health and Human Services75D30125D20400$11.5M
FIRM FIXED PRICENO SET ASIDE USED.
2025-6 ADULT FLU VACCINES
Department of Health and Human Services75D30125D20399$64,617
FIRM FIXED PRICENO SET ASIDE USED.
PEDIATRIC FLU VACCINES
Department of Health and Human Services75D30126D20723$2,134
FIRM FIXED PRICENO SET ASIDE USED.
ADULT FLU VACCINES
Department of Health and Human Services75D30126D20713$1,860
FIRM FIXED PRICE
8511731821!OTHER MEDICAL
Department of DefenseSPE2D026F0023$500
FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENTNO SET ASIDE USED.
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs36F79719D02740
FIRM FIXED PRICENO SET ASIDE USED.
4600078625!MANUFACTURE/DISTRIBUTOR BR-PHILADELPHIA
Department of DefenseSPE2D017D00020
FIRM FIXED PRICENO SET ASIDE USED.
2 LINE ITEMS FOR ANTI-INTERLEUKIN MONOCLONAL ANTIBODIES FOR ASTHMA (BENRALIZUMAB). AWARDED FOR A BASE YEAR OF 2/15/2021 TO 2/14/2022 PLUS FOUR ONE-YEAR OPTION PERIODS.
Department of Veterans Affairs36E79721D00070
FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENTNO SET ASIDE USED.
65 I B, DRUGS, PHARMACEUTICALS,&HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs36F79719D02740
FIRM FIXED PRICENO SET ASIDE USED.
NEW AWARD FOR ACALABRUTINIB TABLETS (100 MG) WITH ASTRAZENECA PHARMACEUTICALS, LP. PERIOD OF PERFORMANCE IS 06/24/2024 TO 06/23/2025 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs36E79724D00260
FIRM FIXED PRICENO SET ASIDE USED.
NEW AWARD FOR ACALABRUTINIB TABLETS (100 MG) WITH ASTRAZENECA PHARMACEUTICALS, LP. PERIOD OF PERFORMANCE IS 06/24/2024 TO 06/23/2025 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs36E79724D00260
Related insights
Spend by Year
Annual obligated spend trend
Top Agencies
Spend distribution by awarding agency